Jiaying Chi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jiaying Chi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chai Nien Foo
Centre for Cancer Research, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, Selangor, Malaysia
1 shared publication - Hemaniswarri Dewi Dewadas
Centre for Biomedical and Nutrition Research, Faculty of Science, Universiti Tunku Abdul Rahman, Kampar 31900, Perak, Malaysia
1 shared publication - Yang Mooi Lim
Centre for Cancer Research, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, Selangor, Malaysia
1 shared publication - Yu Shan Tan
Centre for Cancer Research, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Kajang 43000, Selangor, Malaysia
1 shared publication
Latest Publications
- Open Access
Animal Studies on the Effects of Edible Bird’s Nest on Cognitive Function and Neuroprotection: A Systematic Review
Objectives: This systematic review aims to evaluate the effects of Edible Bird’s Nest (EBN) extract on cognitive function and neuroprotection in animal models and systematically review the relevant research evidence. Methods: A systematic search was conducted in the databases of PubMed, Scopus, Web of Science, EMBASE, Taylor Francis, Wiley, and Cochrane Library for relevant research published up to October 2025. Search terms included “Edible Bird’s Nest”, “Bird’s Nest Extract”, “EBN”, “Swiftlet nest”, “Collocalia”, “Cognitive”, “Memory”, “Learning”, “Neuroprotection”, “Brain”, “Neural”, “Neurotrophic”, “Animal”, “Mice”, “Mouse”, “Rat”, “Rats”, “In vivo”, and “Model”. Two researchers independently screened all the relevant articles, extracted relevant data, and assessed the quality of included studies using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk of bias assessment tool. Results: This systematic review included 11 animal studies, primarily focused on rodent models. Preclinical evidence suggests that Edible Bird’s Nest extract (EBN) may improve performance in several cognitive function tests. Animals treated with EBN appeared to show enhanced spatial memory and learning abilities in experimental settings. At the molecular level, the EBN treatment group showed improved antioxidant capacity and reduced neuroinflammation. Additionally, EBN promoted the expression of neuroprotective factors and enhanced synaptic plasticity. Research suggests that appropriate doses of EBN may have beneficial effects on cognitive enhancement and can alleviate cognitive dysfunction and neuropathological changes. Conclusions: Preliminary evidence from this systematic review suggests that EBN appears to show protective and potentially enhancing effects on cognitive function in animal models. EBN works through multiple mechanisms, including antioxidant and anti-inflammatory effects, as well as promoting the expression of neurotrophic factors and synaptic plasticity. These findings provide initial support for further investigation of EBN as a potential neuroprotective agent and cognitive enhancer. However, there is heterogeneity and methodological limitations in the research, and more standardized studies and preclinical translational research are needed to further validate the application potential of EBN in neuroprotection. These results provide an important reference for developing EBN-based functional foods and supplements for the prevention and adjuvant treatment of cognitive impairment and neurodegenerative diseases.
Open AccessAnimal Studies on the Effects of Edible Bird’s Nest on Cognitive Function and Neuroprotection: A Systematic Review
Objectives: This systematic review aims to evaluate the effects of Edible Bird’s Nest (EBN) extract on cognitive function and neuroprotection in animal models and systematically review the relevant research evidence. Methods: A systematic search was conducted in the databases of PubMed, Scopus, Web of Science, EMBASE, Taylor Francis, Wiley, and Cochrane Library for relevant research published up to October 2025. Search terms included “Edible Bird’s Nest”, “Bird’s Nest Extract”, “EBN”, “Swiftlet nest”, “Collocalia”, “Cognitive”, “Memory”, “Learning”, “Neuroprotection”, “Brain”, “Neural”, “Neurotrophic”, “Animal”, “Mice”, “Mouse”, “Rat”, “Rats”, “In vivo”, and “Model”. Two researchers independently screened all the relevant articles, extracted relevant data, and assessed the quality of included studies using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk of bias assessment tool. Results: This systematic review included 11 animal studies, primarily focused on rodent models. Preclinical evidence suggests that Edible Bird’s Nest extract (EBN) may improve performance in several cognitive function tests. Animals treated with EBN appeared to show enhanced spatial memory and learning abilities in experimental settings. At the molecular level, the EBN treatment group showed improved antioxidant capacity and reduced neuroinflammation. Additionally, EBN promoted the expression of neuroprotective factors and enhanced synaptic plasticity. Research suggests that appropriate doses of EBN may have beneficial effects on cognitive enhancement and can alleviate cognitive dysfunction and neuropathological changes. Conclusions: Preliminary evidence from this systematic review suggests that EBN appears to show protective and potentially enhancing effects on cognitive function in animal models. EBN works through multiple mechanisms, including antioxidant and anti-inflammatory effects, as well as promoting the expression of neurotrophic factors and synaptic plasticity. These findings provide initial support for further investigation of EBN as a potential neuroprotective agent and cognitive enhancer. However, there is heterogeneity and methodological limitations in the research, and more standardized studies and preclinical translational research are needed to further validate the application potential of EBN in neuroprotection. These results provide an important reference for developing EBN-based functional foods and supplements for the prevention and adjuvant treatment of cognitive impairment and neurodegenerative diseases.
- Open Access
- 13 March 2025
- Published by EWA Publishing in Theoretical and Natural Science
- Vol. 96 (1) , 15-19
Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Huntington's Disease
Neurodegenerative diseases are characterized by the progressive loss of neurons or their myelin sheaths, leading to dysfunction and worsening over time. In Alzheimer's disease (AD) and Huntington's disease (HD), certain specific types of neurons are symmetrically lost in the patient's brain, and these specific neuron losses cause motor, sensory, or conscious disorders of the patient. Induced pluripotent stem cells (iPSCs) are multipotent stem cells obtained through reprogramming of somatic cells. The iPSC of patient origin carries disease-related genetic and epigenetic information, and its differentiation process can reflect the development of the disease to a certain extent. This makes iPSCs an ideal tool for building a variety of disease models, including AD and HD, offering valuable insights into disease mechanisms and potential therapeutic strategies. Since most AD and HD still lack effective treatment methods, clarifying the possible pathogenesis of AD and HD will become a prerequisite and foundation for effective prevention and development of the disease and finding effective treatment methods, which is of great theoretical and practical significance for improving the quality of life and longevity of the elderly.
- 13 March 2025
- Published by EWA Publishing in Theoretical and Natural Science
- Vol. 96 (1) , 15-19
Open AccessApplication of Induced Pluripotent Stem Cells in Alzheimer's Disease and Huntington's Disease
Neurodegenerative diseases are characterized by the progressive loss of neurons or their myelin sheaths, leading to dysfunction and worsening over time. In Alzheimer's disease (AD) and Huntington's disease (HD), certain specific types of neurons are symmetrically lost in the patient's brain, and these specific neuron losses cause motor, sensory, or conscious disorders of the patient. Induced pluripotent stem cells (iPSCs) are multipotent stem cells obtained through reprogramming of somatic cells. The iPSC of patient origin carries disease-related genetic and epigenetic information, and its differentiation process can reflect the development of the disease to a certain extent. This makes iPSCs an ideal tool for building a variety of disease models, including AD and HD, offering valuable insights into disease mechanisms and potential therapeutic strategies. Since most AD and HD still lack effective treatment methods, clarifying the possible pathogenesis of AD and HD will become a prerequisite and foundation for effective prevention and development of the disease and finding effective treatment methods, which is of great theoretical and practical significance for improving the quality of life and longevity of the elderly.
- 1 January 2025
- Published by Francis Academic Press Ltd. in Academic Journal of Medicine & Health Sciences
- Vol. 6 (8)
Research Progress in Pathogenesis and Therapeutic Strategies of Alzheimer's Disease: From Molecular Pathology to Clinical Application
Alzheimer's disease (AD) is currently the most common cognitive impairment disorder and has become a major health concern as the global population ages. Focusing on this area, we systematically reviewed research progress in this field and conducted in-depth discussions from gene expression to clinical application. Studies have shown that significant breakthroughs have been made in molecular pathological changes, innovative diagnostic methods, and the development of treatment strategies. Given the complexity of the disease, its prevention and treatment require a comprehensive, multi-faceted approach. This article focuses on how basic research results can better serve the clinic and explores the principles for formulating individualized treatment plans. The latest research progress not only enriches the theoretical basis for clinical practice but also provides new ideas for future research.
- 1 January 2025
- Published by Francis Academic Press Ltd. in Academic Journal of Medicine & Health Sciences
- Vol. 6 (8)
Research Progress in Pathogenesis and Therapeutic Strategies of Alzheimer's Disease: From Molecular Pathology to Clinical Application
Alzheimer's disease (AD) is currently the most common cognitive impairment disorder and has become a major health concern as the global population ages. Focusing on this area, we systematically reviewed research progress in this field and conducted in-depth discussions from gene expression to clinical application. Studies have shown that significant breakthroughs have been made in molecular pathological changes, innovative diagnostic methods, and the development of treatment strategies. Given the complexity of the disease, its prevention and treatment require a comprehensive, multi-faceted approach. This article focuses on how basic research results can better serve the clinic and explores the principles for formulating individualized treatment plans. The latest research progress not only enriches the theoretical basis for clinical practice but also provides new ideas for future research.